secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001641172-25-005780
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical adds VP Marketing, Director HR, raises ~$2.3M from option exercises ahead of FDA decision
--------------------------------------------------------------------------------

- Issued 1,533,336 common shares upon exercise of Series F and Series E preferred investment options at $1.50/share, generating ~$2.3M gross proceeds.
- Appointed Allison Rosefort as VP of Marketing; she brings 15+ years MedTech marketing experience, most recently at Topcon Healthcare.
- Appointed Lisa Dobbins as Director, Human Resources; she previously was HR Business Partner at Integra LifeSciences.
- Company preparing for U.S. commercial launch of LIBERTY Endovascular Robotic System ahead of expected FDA decision in Q2 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000164117225005780/0001641172-25-005780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000164117225005780/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer